Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

XLVI

State Street Health Care Select Sector SPDR Premium Income Fund

The XLVI Exchange Traded Fund (ETF) is provided by State Street Investment Management. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$26.33
+$0.25 (+0.94%) yesterday
1:30 PM 07/23/26 Closed
1D price range
$26.16$26.34
52W price range
$23.99$27.09
YTD Perf.
+5.20%
YTD Flows
Annualized volatility
Fund AuM
€16M
Share class AuM
€16M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US81369Y7461
TER
0.35%
Inception date
7/30/2025
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 22, 2026
-6%-4%-2%0%2%4%6%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
100.33%
Consumer Non-Cyclicals
2.37%
Latest XLVI news

No content available for this fund

FAQ about XLVI

XLVI is a Active ETF. This ETF provides exposure to Large Cap US Health Care Equities.
XLVI carries a total expense ratio (TER) of 0.35%, indicating the annual cost for holding the fund.
XLVI was introduced to the market on July 30, 2025. It trades on United States
State Street Health Care Select Sector SPDR Premium Income Fund, XLVI, is provided by State Street Investment Management. Learn more about State Street Investment Management here.
XLVI oversees €16M in assets as of July 22, 2026.
XLVI follows a distributing dividend policy, meaning it pays out income to investors.
As of June 30, 2026, XLVI has significant geographic allocations in USA and Ireland.
As of June 30, 2026, XLVI focuses largely on Healthcare and Consumer Non-Cyclicals.
As of June 30, 2026, XLVI holds 59 positions in its portfolio, with 74.76% of assets concentrated in its top 15 holdings.
As of June 30, 2026, XLVI top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of XLVI is USD.
Data as of 06/30/26
Eli Lilly & Co.
17.01%
Johnson & Johnson
10.96%
AbbVie, Inc.
7.97%
UnitedHealth Group, Inc.
6.77%
Merck & Co., Inc.
5.69%
Amgen, Inc.
3.50%
Thermo Fisher Scientific, Inc.
3.34%
Abbott Laboratories
2.83%
Gilead Sciences, Inc.
2.81%
Intuitive Surgical, Inc.
2.53%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight